N.Y. Labor Law § 27-F
Requiring first aid materials in a workplace to include an opioid antagonist
New York · New York Labor Law · Status: effective · Effective 2026-02-20
Cite this
- Citation
- N.Y. Labor Law § 27-F, Requiring first aid materials in a workplace to include an opioid antagonist, New York, version 1 as recorded 2026-07-25, yourstate.us, https://yourstate.us/provision/1113698
- Permanent ID
ys:prov:1113698@1- SHA-256
369988f590a1073c0fae818cb757ceffcf042b0b8b77fa5a14b3f986a0d3013c
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
* § 27-f. Requiring first aid materials in a workplace to include an
opioid antagonist. 1. All employers that are federally mandated by the
United States Occupational Safety and Health Act of 1970 (Public Law,
91-596) and safety and health standards promulgated thereunder to have
first aid supplies readily available for the treatment of all injured
employees must have an opioid antagonist available for use in providing
first aid or emergency treatment at the workplace.
2. For the purposes of this section, the following terms shall have
the following meanings:
(a) "Employer" includes any person, corporation, limited liability
company, or association employing any individual in any occupation,
industry, trade, business, or service. The term "employer" shall not
include the state, any political subdivision of the state, a public
authority or any other governmental agency or instrumentality thereof.
(b) "Opioid antagonist" means the same as defined in section
thirty-three hundred nine of the public health law.
3. Administering an opioid antagonist pursuant to this section shall
be considered first aid or emergency treatment for purposes of section
three thousand-a of the public health law.
4. The commissioner shall promulgate regulations, in coordination with
the commissioner of health, to address the appropriate number of opioid
antagonists for workplaces based on the size of the workplace; the
training of personnel and use of such opioid antagonists; and any other
matter deemed necessary by such commissioner to effectuate this section.
* NB Effective December 12, 2026